Verrica Pharmaceuticals Inc (VRCA)
0.8069
-0.06
(-6.53%)
USD |
NASDAQ |
Nov 15, 11:33
Verrica Pharmaceuticals Cash and Short Term Investments (Quarterly): 22.96M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 22.96M |
| June 30, 2024 | 31.93M |
| March 31, 2024 | 48.94M |
| December 31, 2023 | 69.55M |
| September 30, 2023 | 84.31M |
| June 30, 2023 | 55.14M |
| March 31, 2023 | 59.95M |
| December 31, 2022 | 34.27M |
| September 30, 2022 | 39.45M |
| June 30, 2022 | 14.40M |
| March 31, 2022 | 21.90M |
| December 31, 2021 | 70.35M |
| September 30, 2021 | 79.50M |
| June 30, 2021 | 90.13M |
| Date | Value |
|---|---|
| March 31, 2021 | 87.69M |
| December 31, 2020 | 65.47M |
| September 30, 2020 | 71.88M |
| June 30, 2020 | 79.62M |
| March 31, 2020 | 88.38M |
| December 31, 2019 | 62.02M |
| September 30, 2019 | 71.08M |
| June 30, 2019 | 78.75M |
| March 31, 2019 | 83.28M |
| December 31, 2018 | 89.81M |
| September 30, 2018 | 96.98M |
| June 30, 2018 | 103.15M |
| March 31, 2018 | 27.48M |
| December 31, 2017 | 8.663M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
14.40M
Minimum
Jun 2022
90.13M
Maximum
Jun 2021
58.89M
Average
63.74M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 930.44M |
| Elite Pharmaceuticals Inc | 8.407M |
| Eagle Pharmaceuticals Inc | 15.35M |
| TELA Bio Inc | 17.30M |
| Terns Pharmaceuticals Inc | 225.30M |